ISTA Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2010

IRVINE, Calif., Sept. 1 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will present at the Stifel Nicolaus Healthcare Conference 2010 at 11:30 a.m. Eastern Time on September 16, 2010, in Boston, MA. ISTA's President and Chief Executive Officer Vicente Anido, Jr., Ph.D., will provide an update on the Company's competitive position and strategy, plus participate in a brief fireside chat.

The presentation will be webcast. To access the live audio broadcast of the presentation, or the subsequent archived recording, log onto http://www.istavision.com. Please connect to the website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

ABOUT ISTA PHARMACEUTICALS

ISTA Pharmaceuticals, Inc. is the fourth largest and fastest growing branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The Company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain and nasal allergies. Headquartered in Irvine, California, the Company generated 2009 revenues of $111 million. For additional information about ISTA Pharmaceuticals, please visit the corporate website at www.istavision.com.

SOURCE ISTA Pharmaceuticals, Inc.